Docbot is an artificial intelligence technology company focusing on gastrointestinal (GI) disease. Docbot's products are built on the UltivisionAI software platform for real-time image analysis, automated reporting, and analytic tools to improve patient care and clinical workflows. UltivisionAI is an investigational device and has not received FDA clearance.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/23/21 | $4,000,000 | Series A |
Bold Capital Boutique Venture Partners Collaborative Fund | undisclosed |
